BioHarvest Sciences Announces a Private Placement of up to USD $5 Million and Conversion of Debt Notes
Vancouver, British Columbia and Rehovot, Israel – June 21, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCD), announced today that its board of directors have approved a private placement of up to 697,350 units at a price of USD $7.17 per unit (approx. CAD $9.82) for gross proceeds of up to […]